Join us now
The Calcitonin Gene-Related Peptide (CGRP) Forum has been established by an international group of clinicians and researchers. It provides all healthcare professionals with open and free access to independent news, information, comment and resources about the exciting potential of CGRP as a novel therapeutic target for the prevention of migraine in millions of people worldwide.
Why are new migraine treatments needed?
Migraine is the third most common disease worldwide and current treatments are often ineffective and poorly tolerated.
Read more Become a member
Why is CGRP an important therapeutic target?
Multiple lines of evidence support a role for CGRP in migraine pathophysiology.
Its blockade is now a potentially important therapeutic target for migraine prevention.
Read more Become a member
From the Editors
Our distinguished Editors discuss the latest developments and provide their views:Will CGRP antibodies put an end to migraine?View all articlesTrials
Easy-to-access digests of all the key trials completed & ongoing:Eptinezumab (ALD403)Erenumab (AMG 334)Galcanezumab (LY2951742)Fremanezumab (TEV-48125)View all TrialsEducational Resources
Slides, videos and much more free to download: Migraine prevention: Why we need new therapeutic approachesA background to CGRP and its receptorView all Resources
